このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Poseida Therapeutics マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Kristin Yarema
最高経営責任者
US$2.6m
報酬総額
| CEO給与比率 | 14.7% |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 2.4yrs |
| 取締役会の平均在任期間 | 3.1yrs |
経営陣の近況
Recent updates
Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry?
May 21
Investors Don't See Light At End Of Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) Tunnel And Push Stock Down 27%
Apr 09Poseida: April 2024 Data Could Shed Light On Differentiated CAR-T Advancement
Mar 17Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry?
Jan 24Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) Share Price Boosted 43% But Its Business Prospects Need A Lift Too
Dec 18New Forecasts: Here's What Analysts Think The Future Holds For Poseida Therapeutics, Inc. (NASDAQ:PSTX)
Aug 13Little Excitement Around Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) Revenues As Shares Take 44% Pounding
Apr 17Poseida Therapeutics: Collaboration Agreement With Roche Helps Validate Genetic Engineering Tech
Sep 04Poseida Therapeutics GAAP EPS of -$0.69 beats by $0.08, revenue of $2.7M beats by $1.77M
Aug 11Poseida jumps 56% as Roche eyes CAR-T drugs in deal worth up to $6B
Aug 03Earnings Release: Here's Why Analysts Cut Their Poseida Therapeutics, Inc. (NASDAQ:PSTX) Price Target To US$16.25
May 15Poseida Therapeutics: Genome Engineering For Safer Cell Therapies
Oct 30What Type Of Shareholders Make Up Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) Share Registry?
Mar 19Did Poseida Therapeutics, Inc. (NASDAQ:PSTX) Insiders Buy Up More Shares?
Jan 25Poseida Therapeutics (PSTX) Presents At 62nd Virtual Annual Meeting of ASH - Slideshow
Dec 09FDA lifts clinical hold on Poseida's prostate cancer cell therapy study
Nov 02CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$109m |
| Dec 31 2023 | US$3m | US$381k | -US$123m |
報酬と市場: Kristinの 総報酬 ($USD 2.58M ) は、 US市場 ($USD 1.58M ) の同規模の企業の平均を上回っています。
報酬と収益: Kristinの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Kristin Yarema (53 yo)
less than a year
在職期間
US$2,581,106
報酬
Dr. Kristin Yarema Ph.D. is President & CEO of Poseida Therapeutics, Inc. from January 01, 2024 and serves as its Director since January 2024. Dr. Yarema, was the Chief Commercial Officer and Senior Vice P...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.4yrs | US$3.82m | 0.15% $ 384.1k | |
| President | less than a year | US$2.58m | データなし | |
| Chief Financial Officer | 3.9yrs | データなし | 0.073% $ 187.3k | |
| Chief Operations Officer | 2.4yrs | データなし | データなし | |
| Chief People & Administration Officer | 5.4yrs | データなし | データなし | |
| Senior VP of Investor Relations & Corporate Communications | less than a year | データなし | データなし | |
| General Counsel | 3.9yrs | US$978.34k | 0.041% $ 103.8k | |
| Chief Scientific Officer of Cell Therapy | 4.3yrs | データなし | データなし | |
| Senior Vice President of Regulatory Affairs | 2.7yrs | データなし | データなし | |
| Senior VP & Chief Patent Counsel | 2.4yrs | データなし | データなし | |
| Senior Vice President of Business Development | 2.4yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | データなし |
2.4yrs
平均在職期間
57yo
平均年齢
経験豊富な経営陣: PSTXの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.4yrs | US$3.82m | 0.15% $ 384.1k | |
| President | less than a year | US$2.58m | データなし | |
| Lead Independent Director | 5.9yrs | US$175.11k | 0.041% $ 103.7k | |
| Chairman of Cell Therapy Scientific Advisory Board | 3.3yrs | データなし | データなし | |
| Chairman of Gene Therapy Scientific Advisory Board | 1.9yrs | データなし | データなし | |
| Independent Director | 5.4yrs | US$149.11k | 0.051% $ 130.2k | |
| Independent Director | 2.9yrs | US$155.28k | 0.041% $ 103.7k | |
| Independent Director | 2.1yrs | US$150.28k | 0.047% $ 121.0k | |
| Independent Director | 3.5yrs | US$140.11k | 0.041% $ 103.7k | |
| Member of Scientific Advisory Board | 3.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 3.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 3.1yrs | データなし | データなし |
3.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: PSTXの 取締役会 は 経験豊富 であると考えられます ( 3.1年の平均在任期間)。